| Literature DB >> 22617506 |
Giuseppe Santarpino1, Steffen Pfeiffer, Giovanni Concistrè, Theodor Fischlein.
Abstract
The Perceval S bioprosthesis (21 and 23 mm) was approved for clinical use in December 2010 and it is now routinely used. This bioprosthesis is suggested for the treatment of patients undergoing minimally-invasive surgery for reasons of safety and reduction in implantation time. Here we describe the use of the Perceval bioprosthesis in patients undergoing minimally invasive cardiac surgery.Entities:
Mesh:
Year: 2012 PMID: 22617506 PMCID: PMC3422919 DOI: 10.1093/icvts/ivs149
Source DB: PubMed Journal: Interact Cardiovasc Thorac Surg ISSN: 1569-9285